REPEAT Taro Pharmaceutical Industries
Selected Abstract
REPEAT/Taro Pharmaceutical Industries announces FDA approval for clotrimazole solution; fourth ANDA approval of 1996.
HAWTHORNE, N.YBUSINESS WIREJuly 30, 1996--Taro Pharmaceutical Industries Ltd. (Nasdaq/NMS:TAROF) Tuesday reported its wholly owned subsidiary, Taro Pharmaceuticals Inc., of Ontario, Canada, has received notification from the U.S. Food and Drug Administration ( FDA ) approving its Abbreviated New ...
July 31, 1996; Business Wire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
REPEAT/Taro Pharmaceutical Industries announces FDA approval for clotrimazole solution; fourth ANDA approval of 1996.
|